NCT03492437 2023-08-07
Effect of Tepotinib on the PK of the P-gp Substrate Dabigatran Etexilate
Merck KGaA, Darmstadt, Germany
Phase 1 Completed
Clinical Trials
4 trialsNCT05347979 2023-02-09
Effect of Relacorilant on the Pharmacokinetics of the Sensitive P-glycoprotein Substrate Dabigatran Etexilate in Healthy Participants
Corcept Therapeutics
Phase 1 Completed
NCT05368805 2022-10-06
Fruquintinib DDI Study With P-gp and BCRP Substrates
Hutchmed
Phase 1 Completed
NCT03237416 2018-11-06
Drug-drug-interaction Study to Assess the Effect of Darolutamide on the Pharmacokinetics of Probe Substrates of CYP3A4 and P-gp in Healthy Male Volunteers
Bayer
Phase 1 Completed